142 related articles for article (PubMed ID: 17431116)
1. Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer.
Yokoyama Y; Xin B; Shigeto T; Umemoto M; Kasai-Sakamoto A; Futagami M; Tsuchida S; Al-Mulla F; Mizunuma H
Mol Cancer Ther; 2007 Apr; 6(4):1379-86. PubMed ID: 17431116
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
Shigeto T; Yokoyama Y; Xin B; Mizunuma H
Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
[TBL] [Abstract][Full Text] [Related]
3. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
Yokoyama Y; Xin B; Shigeto T; Mizunuma H
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1219-28. PubMed ID: 21681689
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice.
Hirakawa H; Yokoyama Y; Yoshida H; Mizunuma H
J Ovarian Res; 2014 Jan; 7():4. PubMed ID: 24410765
[TBL] [Abstract][Full Text] [Related]
6. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
[TBL] [Abstract][Full Text] [Related]
7. Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model.
Wang L; Chen H; Pourgholami MH; Beretov J; Hao J; Chao H; Perkins AC; Kearsley JH; Li Y
PLoS One; 2011; 6(9):e24405. PubMed ID: 21931707
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer.
Qiao L; Dai Y; Gu Q; Chan KW; Zou B; Ma J; Wang J; Lan HY; Wong BC
Mol Cancer Ther; 2008 Jul; 7(7):2203-11. PubMed ID: 18645029
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis.
Terzuoli E; Donnini S; Giachetti A; Iñiguez MA; Fresno M; Melillo G; Ziche M
Clin Cancer Res; 2010 Aug; 16(16):4207-16. PubMed ID: 20682710
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
11. The homeoprotein DLX4 controls inducible nitric oxide synthase-mediated angiogenesis in ovarian cancer.
Trinh B; Ko SY; Haria D; Barengo N; Naora H
Mol Cancer; 2015 Apr; 14():97. PubMed ID: 25924901
[TBL] [Abstract][Full Text] [Related]
12. Aqueous Extract of Paris polyphylla (AEPP) Inhibits Ovarian Cancer via Suppression of Peroxisome Proliferator-Activated Receptor-Gamma Coactivator (PGC)-1alpha.
Wang CW; Tai CJ; Choong CY; Lin YC; Lee BH; Shi YC; Tai CJ
Molecules; 2016 Jun; 21(6):. PubMed ID: 27271583
[TBL] [Abstract][Full Text] [Related]
13. Down regulation of hepatic PPARalpha function by AhR ligand.
Shaban Z; El-Shazly S; Abdelhady S; Fattouh I; Muzandu K; Ishizuka M; Kimura K; Kazusaka A; Fujita S
J Vet Med Sci; 2004 Nov; 66(11):1377-86. PubMed ID: 15585952
[TBL] [Abstract][Full Text] [Related]
14. Aspirin inhibits MMP-9 mRNA expression and release via the PPARalpha/gamma and COX-2/mPGES-1-mediated pathways in macrophages derived from THP-1 cells.
Xue J; Hua YN; Xie ML; Gu ZL
Biomed Pharmacother; 2010 Feb; 64(2):118-23. PubMed ID: 19880272
[TBL] [Abstract][Full Text] [Related]
15. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer.
Hasumi Y; Mizukami H; Urabe M; Kohno T; Takeuchi K; Kume A; Momoeda M; Yoshikawa H; Tsuruo T; Shibuya M; Taketani Y; Ozawa K
Cancer Res; 2002 Apr; 62(7):2019-23. PubMed ID: 11929819
[TBL] [Abstract][Full Text] [Related]
16. VEGF antibody plus cisplatin reduces angiogenesis and tumor growth in a xenograft model of ovarian cancer.
Ghosh S; Maity P
J Environ Pathol Toxicol Oncol; 2010; 29(1):17-30. PubMed ID: 20528744
[TBL] [Abstract][Full Text] [Related]
17. Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.
Klukovits A; Schally AV; Szalontay L; Vidaurre I; Papadia A; Zarandi M; Varga JL; Block NL; Halmos G
Cancer; 2012 Feb; 118(3):670-80. PubMed ID: 21751186
[TBL] [Abstract][Full Text] [Related]
18. Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
Yoshida M; Taguchi A; Kawana K; Adachi K; Kawata A; Ogishima J; Nakamura H; Fujimoto A; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Arimoto T; Koga K; Wada-Hiraike O; Oda K; Nagamatsu T; Kiyono T; Osuga Y; Fujii T
PLoS One; 2016; 11(8):e0160330. PubMed ID: 27483433
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.
Byrne AT; Ross L; Holash J; Nakanishi M; Hu L; Hofmann JI; Yancopoulos GD; Jaffe RB
Clin Cancer Res; 2003 Nov; 9(15):5721-8. PubMed ID: 14654557
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis, anti-proliferation, tumor-angiogenic suppression and down-regulation of Dalton's Ascitic Lymphoma (DAL) induced tumorigenesis by poly-l-lysine: A mechanistic study.
Debnath S; Mukherjee A; Karan S; Debnath M; Chatterjee TK
Biomed Pharmacother; 2018 Jun; 102():1064-1076. PubMed ID: 29710523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]